Zdrowie i gospodarka · 11/07/2002

FDA Releases Draft Revised Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products

The Food and Drug Administration (FDA) has made available a draft revised guidance document, titled "Bioavailability and Bioequivalence for Orally Administered Drug Products--General Considerations," which aims to improve guidance for pharmaceutical companies conducting bioavailability and bioequivalence studies for orally administered medications.